Posted on 6월 29, 20226/29/22
An Innovative Approach to Comprehensive Key Opinion Leader (KOL) Mapping
Posted on 6월 1, 20226/1/22
New Medicines, New Access, New Frontiers
Posted on 6월 1, 20226/1/22
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Posted on 5월 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on 5월 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 3월 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on 3월 2, 20223/2/22
Succeed When Others Fail: Avoiding 20% in Investment Waste During Launch
Posted on 1월 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on 1월 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on 1월 20, 20221/20/22